FINNENCE ▪ THE WIRE FILE
THE WIRE · № 72858
News■ Unclear/unknown
Fidelity-Backed City Therapeutics Seeks $184.7 Million in US IPO
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-09 11:15 UTC
LAST UPDATE2026-10-09 11:15 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Another biotech IPO filing adds to a cluster of issuance, hinting at improved risk appetite.
Biotech IPO pipeline quietly refilling
CATALYST TO WATCH
Pricing and first-day trading
MAIN RISK
Deal could be pulled on weak demand
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
AFFECTEDSPDR Biotech ETF · XBI
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare, XBI
TRex Bio prices $117M IPO to support immune drug work2026-10-09 11:22 UTC
TRex Bio prices $117M IPO to support immune drug work2026-10-09 11:22 UTC
→CORRELATIONshares Healthcare
Leading Through a Changing Water Management Landscape2026-10-09 11:40 UTC
Leading Through a Changing Water Management Landscape2026-10-09 11:40 UTC
→CORRELATIONshares Healthcare, XBI
TRex prices IPO at bottom of range as Retension makes 'oversized' public debut2026-10-09 11:51 UTC
TRex prices IPO at bottom of range as Retension makes 'oversized' public debut2026-10-09 11:51 UTC
→CORRELATIONshares Healthcare, XBI
TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range2026-10-09 11:54 UTC
TRex Bio raised $116.7 million in a U.S. IPO, pricing at the bottom of its range2026-10-09 11:54 UTC
→CORRELATIONshares Healthcare
HealthWorX Offers Employers a Safer Path to Lower Healthcare Costs as IRS Scrutiny of 105(b) Schemes Grows2026-10-09 12:31 UTC
HealthWorX Offers Employers a Safer Path to Lower Healthcare Costs as IRS Scrutiny of 105(b) Schemes Grows2026-10-09 12:31 UTC
←CORRELATIONshares Healthcare
TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer2026-10-09 06:56 UTC
TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer2026-10-09 06:56 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.